Lidocaine 5% patch 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F7WUU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,912
Award facts
- Contract value 100% obligated
- $4,912.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,912.24 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch in quantities of 30 units. The contract is structured as a firm fixed price delivery order with an ultimate completion date of January 6, 2026, and was competitively awarded without any set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which carries a ceiling value of $999,999,999 through December 2026.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for the federal government's defense and medical supply chain, providing comprehensive pharmaceutical products and medical supplies to support military and veteran healthcare systems. The parent IDC vehicle enables the company to deliver a wide range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic areas to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This specific delivery order for topical pain management medication aligns with AmerisourceBergen's established portfolio of federal medical procurement, demonstrating the company's continued role as a primary vendor for DLA's pharmaceutical supply requirements.
Quick answers
Who was awarded contract SPE2DR26F7WUU?
SPE2DR26F7WUU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 5, 2026.
How much is contract SPE2DR26F7WUU worth?
The government has obligated $4,912 on SPE2DR26F7WUU.
Is contract SPE2DR26F7WUU an order under another contract?
Yes. SPE2DR26F7WUU is a delivery order under SPE2DR25D7061, an indefinite delivery contract.
Was contract SPE2DR26F7WUU competed?
The extent of competition for SPE2DR26F7WUU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award